Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

Jun F. Gu

No. 1278 Baode Road, 
Jing'an, CN 
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
No. 1278 Baode Road, 
Jing'an, CN 
OverviewLocationsClinical Research

Overview

Jun Gu practices in Jing'an, China. Mr. Gu is rated as a Distinguished expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Gallbladder Cancer, Gallbladder Disease, Pancreaticoduodenectomy, and Cardiac Ablation.

His clinical research consists of co-authoring 534 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

No. 1278 Baode Road, Jing'an, 200443, China
Other Locations
No. 639 Zhizaoju Road, Shanghai, 200011, China
No.79 Qingchun Road, Hangzhou, 310003, China
No. 128 Ruili Road, Minhang, 200240, China
1665 Kongjiang Road, Shanghai, 200092, China
899#, Pinghai Road, Suzhou, 215000, China
279 Zhouzhu Road, Pudong, China
168 Changhai Road, Shanghai, 200433, China
No. 170 Xinsong Road, Minhang, 201199, China
301 Yanchang Middle Road, Zhabei, 200072, China
140 Hanzhong Road, Nanjing, China
83 Fenyang Road, Shanghai, 200031, China
241 West Huaihai Road, Huaihai, 200030, China
No. 170 Xinsong Road, Minhang, 201100, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: June 25, 2021
Intervention Type: Drug
Study Phase: Phase 3

534 Total Publications

Interface modifiable bacterial cellulose hydrogel based nerve guidance conduit effectively rehabilitate sciatic nerve injured rat.
Interface modifiable bacterial cellulose hydrogel based nerve guidance conduit effectively rehabilitate sciatic nerve injured rat.
Journal: Biomacromolecules
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gu's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 96 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile